Episode 128 - Finerenone with SGLT2 inhibitors for CKD and Type 2 Diabetes
Update: 2025-07-24
Description
Welcome back Rounds Table Listeners! Today we have a solo episode with Dr. Mike Fralick. This week, he discusses a recently published trial exploring the simultaneous initiation of SGLT2 inhibitors and finerenone (a nonsteroidal mineralocorticoid receptor antagonist) in persons with chronic kidney disease and type 2 diabetes. Here we go!
Calling keen trainees! (9:29 - 10:28 )
- Trainees, med students, residents: The Rounds Table and Trial Files are looking for keen individuals to support our efforts.
- Trial Files is a free monthly newsletter on practice-changing trials, delivered straight to your inbox (https://trialfiles.substack.com/).
- Reach out to fralickmpf@gmail.com if you are interested in getting involved.
Questions? Comments? Feedback? We’d love to hear from you! @roundstable @InternAtWork @MedicinePods
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
